Search Results
Jun 08, 2026, 10:01 ET 2026 Protein Market Report: Whey Supply Crisis, FMCG-Led Growth Surge, and Ingredient Import Disruptions Reshape the $133 Billion Industry
and UK RTD distribution and actively pursuing Asia e-commerce — a direct signal of where the global premium RTD protein market is heading.D2C brands including Myprotein (The Hut Group), Bulk (UK), Form Nutrition, Ghost (US), and OZiva (India) are collectively demonstrating that ingredient transparency
More news about: Market Decipher
Jun 08, 2026, 10:00 ET Fortune Media and Great Place to Work Name DataBank to 2026 Great Place To Work in Texas
have at least 10 U.S. employees, and be headquartered in Texas."Congratulations to the Fortune Best Workplaces in Texas," says Michael C. Bush, CEO of Great Place To Work. "By focusing on people, these companies are more resilient and effective in a business environment that demands
More news about: DataBank
Jun 08, 2026, 10:00 ET The Conference Board Employment Trends Index™ (ETI) Decreased in May
member-driven think tank that delivers trusted insights for what's ahead. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States.
More news about: The Conference Board
Jun 08, 2026, 09:38 ET IPO 추진 소식에 부티카, 새로운 성장 국면 진입 기대
multimedia:https://www.prnewswire.com/kr/news-releases/u0069u0070u006Fu002DuCD94uC9C4u002DuC18CuC2DDuC5D0u002DuBD80uD2F0uCE74u002Cu002DuC0C8uB85CuC6B4u002DuC131uC7A5u002DuAD6DuBA74u002DuC9C4uC785-302794031.htmlSOURCE
More news about: Boutiqaat
Jun 08, 2026, 09:12 ET Therabody lanza CryTherm PalmTM, su primer dispositivo de termorregulación de alto rendimiento
posterior.Características adicionales de CryoTherm Palm:Tres niveles de temperatura fría científicamente calibrados (8 °C, 12 °C y 16 °C) con tecnología criotérmica patentada.Pantalla LCD con cronómetro para el seguimiento de la duración del tratamiento e indicadores de
More news about: Therabody
Jun 08, 2026, 09:10 ET KYOCERA AVX SHOWCASES CUTTING-EDGE RF & MICROWAVE COMPONENT TECHNOLOGIES AT IMS 2026
cutting-edge RF and microwave components, including capacitors, couplers, filters, antennas, inductors, and resistive products engineered to solve complex SWaP-C, performance, and reliability challenges in 5G, 6G, IoT, aerospace, defense, radar, and satcom applications.FOUNTAIN
More news about: KYOCERA AVX
Jun 08, 2026, 09:03 ET EDGE AI FOUNDATION WELCOMES AMAZON WEB SERVICES (AWS) AS A LEADERSHIP PARTNER TO ACCELERATE CLOUD-TO-EDGE AND PHYSICAL AI INNOVATION
www.edgeaifoundation.org.About the EDGE AI FOUNDATIONThe EDGE AI FOUNDATION (a California-based 501(c)(3)) is the world's largest community of edge AI developers, technology makers, and academia, serving as the global hub for energy-efficient edge AI technologies.
More news about: EDGE AI FOUNDATION
Jun 08, 2026, 09:00 ET Rael Brings K-Beauty's Most Advanced Skincare Ingredients to U.S. Shelves with Two New Hydrogel Masks at Ulta Beauty
Glutathione + Vitamin C Brightening Hydrogel Mask. Both bring cutting-edge Korean skincare technology to U.S. consumers. Single masks are available on Ulta.com
More news about: Rael
Jun 08, 2026, 09:00 ET Energration and Atombeam Submit DARPA Proposal to Advance Mission-Ready Tactical Data Movement
warfighting," said Rear Admiral (Ret.) C.D. "Boris" Becker, former Commander of the Naval Information Warfare Command and Program Executive Officer for C4I & Space, and a member of Atombeam's board. "We see Neurpac as a force multiplier in today's battlespace, where the ability to move data quickly,
More news about: Atombeam
Jun 08, 2026, 09:00 ET Labaton Keller Sucharow LLP Announces Pendency and Proposed Settlement of Class Action Involving Purchasers of Estée Lauder Securities
www.EsteeLauderSecuritiesSettlement.com, or by contacting the Claims Administrator at:Estée Lauder Securities Settlementc/o EpiqP.O. Box 5983Portland, OR 97228-59831 (877) 357-1477
More news about: UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
Jun 08, 2026, 09:00 ET New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
12-month study showed clinically significant improvements for participants, with lower A1C levels and improved diabetes self-management, overall diet quality and food security, and a
More news about: Abbott
Jun 08, 2026, 08:51 ET Global Enterprises Face AI Scaling Crisis: 77% View AI as Board-Level Priority, Yet Two-Thirds Rely on Legacy Infrastructure
2026 across markets including the US, UK, Germany, France, Singapore, Hong Kong, China, India, and the Benelux/Nordic regions. 65% of respondents are C-suite executives, and 35% are VP-level or above.Forward-looking and cautionary statementsCertain words and statements in this release concerning
More news about: Tata Communications
Jun 08, 2026, 08:50 ET Therabody、初の体温調節パフォーマンスデバイス「CryoTherm™ Palm」を発表し、科学的裏付けのある手のひら冷却でスポーツの大舞台における暑さ対策をサポート
ーの両方を1台のデバイスで行うことができます。CryoTherm Palmのその他の特徴：独自のCryothermal技術による、科学的に調整された3段階の冷却温度レベル（46.4°F / 8°C、53.6°F / 12°C、60.8°F / 16°C）使用時間を追跡するためのストップウォッチ付きLCDディスプレイと温度ステータスインジケータークイックスタートを可能にする、最後に使用した設定を呼び出す設定メモリー最大120分間のバッテリー駆動時間、USB-C経由で充電可能転がり防止機能とトラベルロックを備えたポータブルなデザイン（トラベルポーチ付属）CryoTherm
More news about: Therabody
Jun 08, 2026, 08:50 ET Xinhua Silk Road: 포시도니아 차이나 나이트, 국제 해양 교류 및 협력을 위한 고위급 플랫폼 제공
multimedia:https://www.prnewswire.com/kr/news-releases/u0078u0069u006Eu0068u0075u0061u002Du0073u0069u006Cu006Bu002Du0072u006Fu0061u0064u003Au002DuD3ECuC2DCuB3C4uB2C8uC544u002DuCC28uC774uB098u002D-302793984.htmlSOURCE
More news about: Xinhua Silk Road
Jun 08, 2026, 08:46 ET Global Enterprises Face AI Scaling Crisis: 77% View AI as Board-Level Priority, Yet Two-Thirds Rely on Legacy Infrastructure
2026 across markets including the US, UK, Germany, France, Singapore, Hong Kong, China, India, and the Benelux/Nordic regions. 65% of respondents are C-suite executives, and 35% are VP-level or above.Forward-looking and cautionary statementsCertain words and statements in this release concerning
More news about: Tata Communications
Jun 08, 2026, 08:40 ET CrowdHealth Unveils Bold New Program to Reverse Type 2 Diabetes
transparent pricing. The initiative is engineered to reverse the trajectory of the disease, aiming for definitive patient outcomes including lower A1c levels, sustained weight loss, and freedom from lifelong medication."The healthcare system profits when people stay sick, not when they get better,"
More news about: CrowdHealth
Jun 08, 2026, 08:38 ET 6lock Releases Inaugural Wire Fraud Report: Compliance Posture No Longer Protects PE Firms from Fiduciary Liability
Commodities case shows what exposure looks like in practice: after losing $5.9 million to wire fraud, Tillage sued its fund administrator, SS&C Technologies, despite compliance frameworks and certifications being in place. The court found "reckless disregard" of red flags. Tillage never recovered,
More news about: 6lock
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
Author: Yuna Chae, Lead Research Scientist, Dong-A ST Research CenterAbstract Control Number: 3043-LBSession: 22-C Integrated Physiology—LiverThe late-breaking preclinical study evaluating vanoglipel in combination with resmetirom demonstrated synergistic
More news about: MetaVia Inc.
Jun 08, 2026, 08:22 ET THERABODY LANCE CRYOTHERM™ PALM, SON PREMIER DISPOSITIF DE THERMORÉGULATION À HAUTE PERFORMANCE, QUI ASSURE UN REFROIDISSEMENT DE LA PAUME SCIENTIFIQUEMENT PROUVÉ POUR GÉRER LA CHALEUR SUR LES PLUS GRANDES SCÈNES SPORTIVES
séance.Autres caractéristiques de CryoTherm Palm :Trois niveaux de froid calibrés scientifiquement (46,4 °F/8 °C, 53,6 °F/12 °C, 60,8 °F/16 °C), alimentés par la technologie Cryothermal exclusiveAffichage LCD avec chronomètre pour le suivi de la durée du traitement et
More news about: Therabody
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
recovery.Additional CryoTherm Palm features:Three scientifically calibrated cold temperature levels (46.4°F / 8°C, 53.6°F / 12°C, 60.8°F / 16°C) powered by proprietary Cryothermal TechnologyLCD display with stopwatch for treatment duration tracking and temperature status
More news about: Therabody
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
recovery.Additional CryoTherm Palm features:Three scientifically calibrated cold temperature levels (46.4°F / 8°C, 53.6°F / 12°C, 60.8°F / 16°C) powered by proprietary Cryothermal TechnologyLCD display with stopwatch for treatment duration tracking and temperature status
More news about: Therabody
Jun 08, 2026, 08:00 ET Vasa Therapeutics to Deliver Two Presentations on VS-041 at ECM2026, Featuring Preclinical and First-in-Human Data and Ongoing Phase 1c Trial Design in HFpEF
preclinical and first-inhuman clinical data on VS-041 in an oral presentation and will describe the rationale and design of the company's ongoing Phase 1c proof-of-mechanism trial.Presentation Details: Oral Presentation: Title: Preclinical Efficacy and Phase 1
More news about: Vasa Therapeutics
Jun 08, 2026, 08:00 ET Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Separations and Related Techniques—Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally
More news about: Waters Corporation
Jun 08, 2026, 08:00 ET Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Separations and Related Techniques—Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally
More news about: Waters Corporation
Jun 08, 2026, 08:00 ET Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
at 12 months, exceeding benchmarks based on medications alone44.8% of high-risk diabetes users achieved at least a 1% eA1c reduction at 12 monthsNEW YORK, June 8, 2026 /PRNewswire/ --
More news about: DarioHealth Corp.